GF
AVEO

Gabelli Funds’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Gabelli Funds’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-262,694
Closed -$3.93M – 1270
2022
Q4 		$3.93M Buy
+262,694
New +$3.64M 0.03% 501

Gabelli Funds's AVEO Position: Q1 2023 in Review

Gabelli Funds sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 262,694 shares — an estimated $3.93M sold.

Gabelli Funds first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $3.93M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Gabelli Funds reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Gabelli Funds sold 262,694 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $3.93M.
  • Gabelli Funds first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Gabelli Funds's AVEO Pharmaceuticals, Inc. position peaked at $3.93M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Gabelli Funds's 13F filing for Q1 2023, filed 12 May 2023.